Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoru Aoyama

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Plos One|August 6, 2025
Evaluation of therapeutic agent selection based on comprehensive genomic profiling in gastroenteropancreatic neuroendocrine neoplasmsSuguru Miyazawa, Hiroaki Ono, Hironari Yamashita, et al.
International Journal of Hematology|June 24, 2021
MPL overexpression induces a high level of mutant-CALR/MPL complex: a novel mechanism of ruxolitinib resistance in myeloproliferative neoplasms with CALR mutationsShunichiro Yasuda, Satoru Aoyama, Ryoto Yoshimoto, et al.
Virology|September 11, 2015
Detection of hypermutated human papillomavirus type 16 genome by Next-Generation SequencingKousho Wakae, Satoru Aoyama, Zhe Wang, et al.
Oncotarget|March 12, 2025
Worldwide Innovative Network (WIN) Consortium in Personalized Cancer Medicine: Bringing next-generation precision oncology to patientsWafik S El-Deiry, Catherine Bresson, Fanny Wunder, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Plos One|August 6, 2025
Evaluation of therapeutic agent selection based on comprehensive genomic profiling in gastroenteropancreatic neuroendocrine neoplasmsSuguru Miyazawa, Hiroaki Ono, Hironari Yamashita, et al.
International Journal of Hematology|June 24, 2021
MPL overexpression induces a high level of mutant-CALR/MPL complex: a novel mechanism of ruxolitinib resistance in myeloproliferative neoplasms with CALR mutationsShunichiro Yasuda, Satoru Aoyama, Ryoto Yoshimoto, et al.
Virology|September 11, 2015
Detection of hypermutated human papillomavirus type 16 genome by Next-Generation SequencingKousho Wakae, Satoru Aoyama, Zhe Wang, et al.
Oncotarget|March 12, 2025
Worldwide Innovative Network (WIN) Consortium in Personalized Cancer Medicine: Bringing next-generation precision oncology to patientsWafik S El-Deiry, Catherine Bresson, Fanny Wunder, et al.
Pageof 2